Literature DB >> 9074569

Role of p53 in drug resistance in ovarian cancer.

A N Shelling1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9074569     DOI： 10.1016/S0140-6736(05)60195-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Drug resistance in lung cancer.

Authors:  Manish Shanker; David Willcutts; Jack A Roth; Rajagopal Ramesh
Journal:  Lung Cancer (Auckl)       Date:  2010-05-08

2.  Targeting p53 for Novel Anticancer Therapy.

Authors:  Zhen Wang; Yi Sun
Journal:  Transl Oncol       Date:  2010-02       Impact factor: 4.243

Review 3.  Apoptosis by p53: mechanisms, regulation, and clinical implications.

Authors:  R V Sionov; Y Haupt
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Drug resistance in ovarian cancer - the role of p53.

Authors:  R Petty; A Evans; I Duncan; C Kurbacher; I Cree
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

5.  Multiple mutation analyses in single tumor cells with improved whole genome amplification.

Authors:  W Dietmaier; A Hartmann; S Wallinger; E Heinmöller; T Kerner; E Endl; K W Jauch; F Hofstädter; J Rüschoff
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

Review 6.  Late onset Li-Fraumeni Syndrome with bilateral breast cancer and other malignancies: case report and review of the literature.

Authors:  Karin Kast; Mechthild Krause; Markus Schuler; Katrin Friedrich; Barbara Thamm; Andrea Bier; Wolfgang Distler; Stefan Krüger
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

7.  Treatment strategy for recurrent and refractory epithelial ovarian cancer: efficacy of high-dose chemotherapy with hematopoietic stem cell transplantation.

Authors:  Toshinari Muramatsu; Takao Shinozuka; Takeshi Hirasawa; Hitomi Tsukada; Hironobu Maeda; Tsuyoshi Miyamoto; Masaru Murakami; Hiroshi Kajiwara; Masanori Yasuda; R Yoshiyuki Osamura; Mikio Mikami
Journal:  Acta Histochem Cytochem       Date:  2006-05-26       Impact factor: 1.938

8.  EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classes.

Authors:  Sheida Nabavi; Daniel Schmolze; Mayinuer Maitituoheti; Sadhika Malladi; Andrew H Beck
Journal:  Bioinformatics       Date:  2015-10-29       Impact factor: 6.937

Review 9.  Mutant p53 in cancer therapy-the barrier or the path.

Authors:  Xiang Zhou; Qian Hao; Hua Lu
Journal:  J Mol Cell Biol       Date:  2019-04-01       Impact factor: 6.216

Review 10.  Therapeutic Inducers of Apoptosis in Ovarian Cancer.

Authors:  Mudra Binju; Monica Angelica Amaya-Padilla; Graeme Wan; Hendra Gunosewoyo; Yohan Suryo Rahmanto; Yu Yu
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.